AbCellera Biologics Inc (ABCL) Up 1.99% in Premarket Trading

AbCellera Biologics Inc (ABCL) is higher by Wednesday morning, with the stock rising 1.99% in pre-market trading to 20. ABCL's short-term technical score of 1 indicates that the stock has traded less bullishly over the last month than 99% of stocks on the market. In the Biotechnology industry, which ranks 139 out of 146 industries, the stock ranks higher than 1% of stocks. AbCellera Biologics Inc has risen 11.55% over the past month, closing at $16.93 on September 1. During this period of time, the stock fell as low as $16.93 and as high as $22.63. ABCL has an average analyst recommendation of Strong Buy. The company has an average price target of $45.25.

ABCL has an Overall Score of 32. Find out what this means to you and get the rest of the rankings on ABCL!

See Full ABCL Report

AbCellera Biologics Inc has a Long-Term Technical rank of 12. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 88% of the market scoring higher. In the Biotechnology industry which is number 131 by this metric, ABCL ranks better than 27% of stocks.

Important Dates for Investors in ABCL:

-AbCellera Biologics Inc is set to release earnings on 11/10/2021. During their last earnings release the company posted EPS of $0.79. -We do not have a set dividend date for AbCellera Biologics Inc at this time. Click Here To Get The Full Report on AbCellera Biologics Inc (ABCL)